Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;96(2):99-105.
doi: 10.1016/j.contraception.2017.05.012. Epub 2017 Jun 5.

One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception

Affiliations

One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception

J N Sanders et al. Contraception. 2017 Aug.

Abstract

Objective(s): This study compares 1-year intrauterine device (IUD) continuation among women presenting for emergency contraception (EC) and initiating the copper (Cu T380A) IUD or the levonorgestrel (LNG) 52 mg IUD plus 1.5 mg oral LNG.

Study design: This cohort study enrolled 188 women who presented at a single family planning clinic in Utah between June 2013 and September 2014 and selected either the Cu T380A IUD or LNG 52 mg IUD plus oral LNG for EC. Trained personnel followed participants by phone, text or e-mail for 12 months or until discontinuation occurred. We assessed reasons for discontinuation and used Cox proportional hazard models, Kaplan-Meier estimates and log-rank tests to assess differences in continuation rates between IUDs.

Results: One hundred seventy-six women received IUDs; 66 (37%) chose the Cu T380A IUD and 110 (63%) chose the LNG 52 mg IUD plus oral LNG. At 1 year, we accounted for 147 (84%) participants, 33 (22%) had requested removals, 13 (9%) had an expulsion and declined reinsertion, 3 (2%) had a pregnancy with their IUD in place and 98 (67%) were still using their device. Continuation rates did not differ by IUD type; 60% of Cu T380A IUD users and 70% of LNG 52 mg IUD plus oral LNG users were still using their device at 12 months (adjusted hazard ratio 0.72, 95% confidence interval 0.40-1.3).

Conclusion(s): Two-thirds of women who chose IUD placement at the EC clinical encounter continued use at 1 year. Women initiating Cu T380A IUD and LNG 52 mg IUD had similar 1-year continuation rates. These findings support same-day insertion of IUDs for women who are seeking EC and would like to use a highly effective reversible method going forward.

Implications: Providing IUD options for EC users presents an opportunity to increase availability of highly effective contraception.

Keywords: Continuation; Copper IUD; Emergency contraception; Levonorgestrel IUD.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: D.K.T. receives speaking honoraria from Allergan, Medicines360, Merck and Teva. He serves on advisory boards for Actavis, Bayer, Pharmanest and Teva. The Department of Obstetrics and Gynecology, University of Utah, receives contraceptive clinical trials research funding from Bayer, Bioceptive, Contramed, Medicines360, Merck and Teva. L.M.G. reports personal fees from Evofem Medical Advisory Meeting, outside the submitted work.

Figures

Fig. 1
Fig. 1
Study flow diagram.
Fig. 2
Fig. 2
Kaplan–Meier survival curve estimating IUD continuation rates by chosen method of emergency contraception. Key: Cu IUD, copper IUD;LNG IUD+, same-day 52 mg levonorgestrel IUD plus 1.5 mg oral levonorgestrel. Sensitivity analysis of (a) best and (b) worst-case scenarios and use of the drop-out event as a study end-point.
Fig. 3
Fig. 3
Forest plot demonstrating IUD continuation rates and 95% confidence intervals for current study and comparator studies. Key: Standard, standard of care IUD start;EC, emergency contraception IUD start.

Similar articles

Cited by

References

    1. Raymond EG, Trussell J, Polis CB. Population effect of increased access to emergency contraceptive pills: a systematic review. Obstet Gynecol. 2007;109:181–8. - PubMed
    1. Glasier A, Fairhurst K, Wyke S, Ziebland S, Seaman P, Walker J, et al. Advanced provision of emergency contraception does not reduce abortion rates. Contraception. 2004;69:361–6. - PubMed
    1. Polis CB, Schaffer K, Blanchard K, Glasier A, Harper CC, Grimes DA. Advance provision of emergency contraception for pregnancy prevention: a meta-analysis. Obstet Gynecol. 2007;110:1379–88. - PubMed
    1. Sanders JN, Turok DK, Gawron LM, Law A, Wen L, Lynen R. Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review. Obstet Gynecol. 2017 - PMC - PubMed
    1. Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117:1105–13. - PMC - PubMed